CONCOMITANT ADMINISTRATION OF RECOMBINANT HUMAN INTERLEUKIN-2 AND RECOMBINANT INTERFERON-ALPHA-2A IN CANCER-PATIENTS - A PHASE-I STUDY

被引：91

作者：

LEE, KH

TALPAZ, M

ROTHBERG, JM

MURRAY, JL

PAPADOPOULOS, N

PLAGER, C

BENJAMIN, R

LEVITT, D

GUTTERMAN, J

机构：

[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT CLIN IMMUNOL & BIOL THERAPY,BOX 41,HOUSTON,TX 77030

[2] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT MED ONCOL,HOUSTON,TX 77030

[3] HOFFMANN LA ROCHE INC,NUTLEY,NJ 07110

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1989年 / 7卷 / 11期

关键词：

D O I：

10.1200/JCO.1989.7.11.1726

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1726 / 1732

页数：7

共 30 条

[1]

BRUNDA MJ, 1984, CANCER RES, V44, P597

[2]

BRUNDA MJ, 1986, NATURAL IMMUNITY CAN, P235

[3]

DJEU JY, 1979, J IMMUNOL, V122, P175

[4] METASTATIC RENAL-CANCER TREATED WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS - A PHASE-II CLINICAL-TRIAL [J].

FISHER, RI ;

COLTMAN, CA ;

DOROSHOW, JH ;

RAYNER, AA ;

HAWKINS, MJ ;

MIER, JW ;

WIERNIK, P ;

MCMANNIS, JD ;

WEISS, GR ;

MARGOLIN, KA ;

GEMLO, BT ;

HOTH, DF ;

PARKINSON, DR ;

PAIETTA, E .

ANNALS OF INTERNAL MEDICINE, 1988, 108 (04) :518-523

[5]

GILLIS S, 1978, J IMMUNOL, V120, P2027

[6]

GRACOMINI P, 1984, J IMMUNOL, V133, P1649

[7] VARIED BIOLOGIC EFFECTS OF INTERFERON [J].

GRESSER, I .

CELLULAR IMMUNOLOGY, 1977, 34 (02) :406-415

[8] LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON - LYSIS OF NATURAL KILLER-RESISTANT FRESH SOLID TUMOR-CELLS BY INTERLEUKIN 2-ACTIVATED AUTOLOGOUS HUMAN PERIPHERAL-BLOOD LYMPHOCYTES [J].

GRIMM, EA ;

MAZUMDER, A ;

ZHANG, HZ ;

ROSENBERG, SA .

JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (06) :1823-1841

[9]

HEFENEIDER SH, 1983, J IMMUNOL, V130, P222

[10] INTERLEUKIN-2 AUGMENTS NATURAL-KILLER CELL-ACTIVITY [J].

HENNEY, CS ;

KURIBAYASHI, K ;

KERN, DE ;

GILLIS, S .

NATURE, 1981, 291 (5813) :335-338

← 1 2 3 →